SEC Form 3 · accession 0000899243-17-020062
Molecular Templates, Inc. · MTEM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Broxson
Director · 10% Owner
Period of report
Aug 1, 2017
Accepted (ET)
Aug 10, 2017 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001183765
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 2,922,993 | I | By Millennium Pharmaceuticals, Inc.(1) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are owned directly by Millennium Pharmaceuticals, Inc. The Reporting Person is the Vice President and Head of R&D Business Development for Takeda Pharmaceutical Company Ltd., of which Millennium Pharmaceuticals, Inc. is a wholly owned subsidiary. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Remarks
Exhibit 24.1 - Power of Attorney